Gene: KSR2
Official Full Name: kinase suppressor of ras 2provided by HGNC
Gene Summary: Enables protein serine/threonine kinase activity. Predicted to be involved in Ras protein signal transduction; calcium-mediated signaling; and positive regulation of cold-induced thermogenesis. Predicted to act upstream of or within positive regulation of MAPK cascade. Predicted to be located in membrane. Predicted to be active in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08859 | KSR2 Knockout cell line (HCT 116) | Human | KSR2 | 1:2~1:4 | Negative | Online Inquiry |
KO08860 | KSR2 Knockout cell line (A549) | Human | KSR2 | 1:3~1:4 | Negative | Online Inquiry |
KSR2 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to disrupt the expression of the KSR2 gene, a critical regulator in various intracellular signaling pathways, particularly those involving the mitogen-activated protein kinase (MAPK) cascade. These cell lines serve as powerful tools for studying the multifaceted roles of KSR2 in cellular processes such as proliferation, differentiation, and metabolism.
The primary mechanism of action of KSR2 gene knockout involves the elimination of KSR2 protein, which affects signal transduction pathways by altering the phosphorylation status of downstream effectors. By utilizing these knockout cell lines, researchers can explore the functional consequences of KSR2 disruption, providing insights into its role in diverse physiological and pathological contexts, from developmental biology to metabolic disorders.
In terms of scientific importance, KSR2 gene knockout cell lines are invaluable in research settings exploring obesity, diabetes, and cancer. The ability to manipulate KSR2 expression allows for the investigation of its contribution to insulin signaling and tumorigenesis, paving the way for the identification of potential therapeutic targets. In clinical settings, findings derived from such studies may influence the development of targeted therapies aimed at modulating KSR2 activity, thus offering novel interventions for metabolic diseases and cancers.
Compared to conventional cell lines, KSR2 gene knockout cell lines present distinct advantages. They provide a precise model for the investigation of genetic perturbations, allowing for more accurate and reproducible results. Additionally, these lines are readily accessible, facilitating their integration into existing research frameworks, and enhancing the overall efficiency of experimental designs.
For researchers and clinicians focused on elucidating the mechanisms of KSR2, our KSR2 Gene Knockout Cell Lines are an essential asset. Their unique ability to model the consequences of gene knockout provides a clear path toward advancing our understanding of critical signaling networks. Our company specializes in the development of innovative biological tools designed to empower scientific inquiry and foster breakthrough discoveries, ensuring that you have the resources necessary to drive your research forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.